How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

907 results for

Acne Vulgaris Management

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

161. Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Pump, Cetaphil® DermaControl™ Moisturizer SPF 30, and Cetaphil® DermaControl™ Foam Wash Regimen in Student Athletes With Mild to Moderate Acne Vulgaris

Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Pump, Cetaphil® DermaControlâ„¢ Moisturizer SPF 30, and Cetaphil® DermaControlâ„¢ Foam Wash Regimen in Student Athletes With Mild to Moderate Acne Vulgaris A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save (...) this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02249104 Recruitment Status : Completed First

2014 Clinical Trials

162. P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris

P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. P2 Multi-center (...) Study of SB204 Gel in the Treatment of Acne Vulgaris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02242760 Recruitment Status : Completed First Posted : September 17, 2014 Last Update Posted : January 11, 2019 Sponsor: Novan, Inc. Information provided by (Responsible Party): Novan, Inc. Study

2014 Clinical Trials

163. Safety and Efficacy Study of CLS001Topical Gel Compared to Vehicle in Subjects With Inflammatory Acne Vulgaris

Safety and Efficacy Study of CLS001Topical Gel Compared to Vehicle in Subjects With Inflammatory Acne Vulgaris Safety and Efficacy Study of CLS001Topical Gel Compared to Vehicle in Subjects With Inflammatory Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved (...) studies (100). Please remove one or more studies before adding more. Safety and Efficacy Study of CLS001Topical Gel Compared to Vehicle in Subjects With Inflammatory Acne Vulgaris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02066545 Recruitment Status : Completed First Posted : February 19, 2014

2014 Clinical Trials

164. Study Of Safety, Tolerability And Effects Of PF-05175157 In Adults With Moderate To Severe Acne Vulgaris

Study Of Safety, Tolerability And Effects Of PF-05175157 In Adults With Moderate To Severe Acne Vulgaris Study Of Safety, Tolerability And Effects Of PF-05175157 In Adults With Moderate To Severe Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100 (...) ). Please remove one or more studies before adding more. Study Of Safety, Tolerability And Effects Of PF-05175157 In Adults With Moderate To Severe Acne Vulgaris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02100527 Recruitment Status : Withdrawn (Study canceled) First Posted : April 1, 2014 Last

2014 Clinical Trials

165. Safety, Tolerability and Pharmacokinetics of AGN-190168 in Subjects With Acne Vulgaris

Safety, Tolerability and Pharmacokinetics of AGN-190168 in Subjects With Acne Vulgaris Safety, Tolerability and Pharmacokinetics of AGN-190168 in Subjects With Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies (...) before adding more. Safety, Tolerability and Pharmacokinetics of AGN-190168 in Subjects With Acne Vulgaris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02218034 Recruitment Status : Completed First Posted : August 15, 2014 Last Update Posted : April 30, 2015 Sponsor: Allergan Information provided

2014 Clinical Trials

166. Pivotal Study of Sebacia Microparticles in the Treatment of Acne Vulgaris

Pivotal Study of Sebacia Microparticles in the Treatment of Acne Vulgaris Pivotal Study of Sebacia Microparticles in the Treatment of Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Pivotal (...) Study of Sebacia Microparticles in the Treatment of Acne Vulgaris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02217228 Recruitment Status : Completed First Posted : August 15, 2014 Last Update Posted : September 18, 2017 Sponsor: Sebacia, Inc. Information provided by (Responsible Party): Sebacia

2014 Clinical Trials

167. CD5789 Long Term Safety Study on Acne Vulgaris

CD5789 Long Term Safety Study on Acne Vulgaris CD5789 (Trifarotene) Long Term Safety Study on Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. CD5789 (Trifarotene) Long Term Safety Study (...) on Acne Vulgaris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02189629 Recruitment Status : Completed First Posted : July 14, 2014 Last Update Posted : July 17, 2018 Sponsor: Galderma R&D Information provided by (Responsible Party): Galderma R&D Study Details Study Description Go to Brief Summary

2014 Clinical Trials

168. Multiple Arm Study of Sebacia Microparticles in the Treatment of Acne Vulgaris

Multiple Arm Study of Sebacia Microparticles in the Treatment of Acne Vulgaris Multiple Arm Study of Sebacia Microparticles in the Treatment of Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) . Multiple Arm Study of Sebacia Microparticles in the Treatment of Acne Vulgaris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02219074 Recruitment Status : Completed First Posted : August 18, 2014 Last Update Posted : September 7, 2017 Sponsor: Sebacia, Inc. Information provided by (Responsible Party

2014 Clinical Trials

169. Generic Tazarotene Cream, 0.1% in the Treatment of Acne Vulgaris

Generic Tazarotene Cream, 0.1% in the Treatment of Acne Vulgaris Generic Tazarotene Cream, 0.1% in the Treatment of Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Generic Tazarotene Cream (...) , 0.1% in the Treatment of Acne Vulgaris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02160678 Recruitment Status : Completed First Posted : June 11, 2014 Last Update Posted : November 3, 2016 Sponsor: G & W Laboratories Inc. Information provided by (Responsible Party): G & W Laboratories Inc

2014 Clinical Trials

170. A 2 Period Cross-over Pharmacokinetic Study of SB204 in Acne Vulgaris

A 2 Period Cross-over Pharmacokinetic Study of SB204 in Acne Vulgaris A 2 Period Cross-over Pharmacokinetic Study of SB204 in Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A 2 Period Cross (...) -over Pharmacokinetic Study of SB204 in Acne Vulgaris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02164084 Recruitment Status : Completed First Posted : June 16, 2014 Last Update Posted : April 3, 2015 Sponsor: Novan, Inc. Information provided by (Responsible Party): Novan, Inc. Study Details

2014 Clinical Trials

171. A Study To Evaluate The Safety And Therapeutic Equivalence of Tazarotene Foam 0.1% in Subjects With Acne Vulgaris

A Study To Evaluate The Safety And Therapeutic Equivalence of Tazarotene Foam 0.1% in Subjects With Acne Vulgaris A Study To Evaluate The Safety And Therapeutic Equivalence of Tazarotene Foam 0.1% in Subjects With Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved (...) studies (100). Please remove one or more studies before adding more. A Study To Evaluate The Safety And Therapeutic Equivalence of Tazarotene Foam 0.1% in Subjects With Acne Vulgaris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02267746 Recruitment Status : Completed First Posted : October 17, 2014

2014 Clinical Trials

172. A Study of Dapsone Gel in Females With Skin of Color and Acne Vulgaris

A Study of Dapsone Gel in Females With Skin of Color and Acne Vulgaris A Study of Dapsone Gel in Females With Skin of Color and Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Study (...) of Dapsone Gel in Females With Skin of Color and Acne Vulgaris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02032407 Recruitment Status : Completed First Posted : January 10, 2014 Results First Posted : August 19, 2015 Last Update Posted : August 19, 2015 Sponsor: Allergan Information provided

2014 Clinical Trials

173. Management of severe acne during pregnancy: A case report and review of the literature Full Text available with Trip Pro

Management of severe acne during pregnancy: A case report and review of the literature The treatment of acne during pregnancy is often limited by the potential toxicities that are posed to the fetus by the most common and effective acne therapies. As with all dermatoses during pregnancy, the treatment of acne vulgaris in this population requires a thorough understanding of the risks and benefits that are inherent to each treatment. We report on a case of a 30-year-old pregnant patient (...) with severe acne conglobata who showed significant improvement with a combination treatment of topical modalities, oral metronidazole, and low dose prednisone during pregnancy. We also review the literature and present an approach for the care of these patients.

2017 International journal of women's dermatology

174. Acne Vulgaris (Treatment)

Acne Vulgaris (Treatment) Acne Vulgaris Treatment & Management: Medical Care, Surgical Care, Consultations Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTA2OTgwNC10cmVhdG1lbnQ= processing > Acne Vulgaris (...) Treatment & Management Updated: Mar 26, 2019 Author: Jaggi Rao, MD, FRCPC; Chief Editor: William D James, MD Share Email Print Feedback Close Sections Sections Acne Vulgaris Treatment Medical Care Treatment should be directed toward the known pathogenic factors involved in acne. These include follicular hyperproliferation, excess sebum, Cutibacterium acnes (formerly Propionibacterium acnes ) infection , and inflammation. The grade and severity of the acne help in determining which of the following

2014 eMedicine.com

175. Acne Vulgaris (Overview)

; ethinyl estradiol and norgestimate; ethinyl estradiol and drospirenone) When a topical or systemic antibiotic is used, it should be used in conjunction with benzoyl peroxide to reduce the emergence of resistance. Nonpharmacotherapy Diet therapy, such as a low-glycemic diet and avoidance of “junk foods,” has been suggested as a nonpharmacologic measure to manage acne vulgaris. Skim milk has been found to have a positive association with acne. Procedures Procedural treatments for acne vulgaris include (...) the program slowly, the skin can adapt to this irritation. Prescriptions should be accompanied by a discussion of the potential adverse effects. For patient education resources, see the as well as the patient education article . Also see the Medscape . Previous References Dawson AL, Dellavalle RP. Acne vulgaris. BMJ . 2013 May 8. 346:f2634. . Thiboutot D, Gollnick H, Bettoli V, Dréno B, Kang S, Leyden JJ, et al. New insights into the management of acne: an update from the Global Alliance to Improve

2014 eMedicine.com

176. Acne Vulgaris (Follow-up)

Acne Vulgaris (Follow-up) Acne Vulgaris Treatment & Management: Medical Care, Surgical Care, Consultations Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTA2OTgwNC10cmVhdG1lbnQ= processing > Acne Vulgaris (...) Treatment & Management Updated: Mar 26, 2019 Author: Jaggi Rao, MD, FRCPC; Chief Editor: William D James, MD Share Email Print Feedback Close Sections Sections Acne Vulgaris Treatment Medical Care Treatment should be directed toward the known pathogenic factors involved in acne. These include follicular hyperproliferation, excess sebum, Cutibacterium acnes (formerly Propionibacterium acnes ) infection , and inflammation. The grade and severity of the acne help in determining which of the following

2014 eMedicine.com

177. Acne Vulgaris (Diagnosis)

; ethinyl estradiol and norgestimate; ethinyl estradiol and drospirenone) When a topical or systemic antibiotic is used, it should be used in conjunction with benzoyl peroxide to reduce the emergence of resistance. Nonpharmacotherapy Diet therapy, such as a low-glycemic diet and avoidance of “junk foods,” has been suggested as a nonpharmacologic measure to manage acne vulgaris. Skim milk has been found to have a positive association with acne. Procedures Procedural treatments for acne vulgaris include (...) the program slowly, the skin can adapt to this irritation. Prescriptions should be accompanied by a discussion of the potential adverse effects. For patient education resources, see the as well as the patient education article . Also see the Medscape . Previous References Dawson AL, Dellavalle RP. Acne vulgaris. BMJ . 2013 May 8. 346:f2634. . Thiboutot D, Gollnick H, Bettoli V, Dréno B, Kang S, Leyden JJ, et al. New insights into the management of acne: an update from the Global Alliance to Improve

2014 eMedicine.com

178. External application of herbal medicines for acne vulgaris: a systematic review and meta-analysis

External application of herbal medicines for acne vulgaris: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address (...) models Example: Heterogeneity will be assessed using the (residual) I2 and adjusted R2 statistics. ">Heterogeneity For further guidance please refer to the and to pre-clinical meta-analysis. Example: Whenever a control group serves more than one experimental group, we will correct the total number of control animals in the meta-analysis by dividing the number of animals in the control group by the number of treatment groups served. Where applicable, Holm-Bonferroni correction for testing multiple

2016 PROSPERO

179. Systematic review and qualitative synthesis of people's experiences of acne vulgaris and its related treatments

Systematic review and qualitative synthesis of people's experiences of acne vulgaris and its related treatments Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence (...) to account for anticipated heterogeneity. ">Effect models Example: Heterogeneity will be assessed using the (residual) I2 and adjusted R2 statistics. ">Heterogeneity For further guidance please refer to the and to pre-clinical meta-analysis. Example: Whenever a control group serves more than one experimental group, we will correct the total number of control animals in the meta-analysis by dividing the number of animals in the control group by the number of treatment groups served. Where applicable, Holm

2016 PROSPERO

180. Oral isotretinoin for acne vulgaris: a systematic review of treatment efficacy and adverse events

Oral isotretinoin for acne vulgaris: a systematic review of treatment efficacy and adverse events Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address (...) models Example: Heterogeneity will be assessed using the (residual) I2 and adjusted R2 statistics. ">Heterogeneity For further guidance please refer to the and to pre-clinical meta-analysis. Example: Whenever a control group serves more than one experimental group, we will correct the total number of control animals in the meta-analysis by dividing the number of animals in the control group by the number of treatment groups served. Where applicable, Holm-Bonferroni correction for testing multiple

2016 PROSPERO

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>